According to this study, over the next five years the General Anesthesia Drugs market will register a 2.8%% CAGR in terms of revenue, the global market size will reach $ 7514.3 million by 2025, from $ 6728.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in General Anesthesia Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of General Anesthesia Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the General Anesthesia Drugs, covering the supply chain analysis, impact assessment to the General Anesthesia Drugs market size growth rate in several scenarios, and the measures to be undertaken by General Anesthesia Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
- Propofol
- Etomidate
- Midazolam
- Sevoflurane
- Isoflurane
- Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
- Intravenous Anesthetics
- Inhalational Anesthetics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
- Astrazeneca
- Nhwa
- Fresenius-Kabi
- Baxter Healthcare
- B.Braun
- AbbVie
- Hikma Pharmaceuticals
- Maruishi
- Mylan
- Piramal
- Hengrui
- Lunan
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
- To study and analyze the global General Anesthesia Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of General Anesthesia Drugs market by identifying its various subsegments.
- Focuses on the key global General Anesthesia Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the General Anesthesia Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of General Anesthesia Drugs submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Global General Anesthesia Drugs Market Growth 2020-2025
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global General Anesthesia Drugs Consumption 2015-2025
2.1.2 General Anesthesia Drugs Consumption CAGR by Region
2.2 General Anesthesia Drugs Segment by Type
2.2.1 Propofol
2.2.2 Etomidate
2.2.3 Midazolam
2.2.4 Sevoflurane
2.2.5 Isoflurane
2.2.6 Others
2.3 General Anesthesia Drugs Consumption by Type
2.3.1 Global General Anesthesia Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global General Anesthesia Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global General Anesthesia Drugs Sale Price by Type (2015-2020)
2.4 General Anesthesia Drugs Segment by Application
2.4.1 Intravenous Anesthetics
2.4.2 Inhalational Anesthetics
2.5 General Anesthesia Drugs Consumption by Application
2.5.1 Global General Anesthesia Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global General Anesthesia Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global General Anesthesia Drugs Sale Price by Type (2015-2020)
3 Global General Anesthesia Drugs by Company
3.1 Global General Anesthesia Drugs Sales Market Share by Company
3.1.1 Global General Anesthesia Drugs Sales by Company (2018-2020)
3.1.2 Global General Anesthesia Drugs Sales Market Share by Company (2018-2020)
3.2 Global General Anesthesia Drugs Revenue Market Share by Company
3.2.1 Global General Anesthesia Drugs Revenue by Company (2018-2020)
3.2.2 Global General Anesthesia Drugs Revenue Market Share by Company (2018-2020)
3.3 Global General Anesthesia Drugs Sale Price by Company
3.4 Global General Anesthesia Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global General Anesthesia Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players General Anesthesia Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 General Anesthesia Drugs by Regions
4.1 General Anesthesia Drugs by Regions
4.2 Americas General Anesthesia Drugs Consumption Growth
4.3 APAC General Anesthesia Drugs Consumption Growth
4.4 Europe General Anesthesia Drugs Consumption Growth
4.5 Middle East & Africa General Anesthesia Drugs Consumption Growth
5 Americas
5.1 Americas General Anesthesia Drugs Consumption by Countries
5.1.1 Americas General Anesthesia Drugs Consumption by Countries (2015-2020)
5.1.2 Americas General Anesthesia Drugs Value by Countries (2015-2020)
5.2 Americas General Anesthesia Drugs Consumption by Type
5.3 Americas General Anesthesia Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC General Anesthesia Drugs Consumption by Regions
6.1.1 APAC General Anesthesia Drugs Consumption by Regions (2015-2020)
6.1.2 APAC General Anesthesia Drugs Value by Regions (2015-2020)
6.2 APAC General Anesthesia Drugs Consumption by Type
6.3 APAC General Anesthesia Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe General Anesthesia Drugs by Countries
7.1.1 Europe General Anesthesia Drugs Consumption by Countries (2015-2020)
7.1.2 Europe General Anesthesia Drugs Value by Countries (2015-2020)
7.2 Europe General Anesthesia Drugs Consumption by Type
7.3 Europe General Anesthesia Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa General Anesthesia Drugs by Countries
8.1.1 Middle East & Africa General Anesthesia Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa General Anesthesia Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa General Anesthesia Drugs Consumption by Type
8.3 Middle East & Africa General Anesthesia Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 General Anesthesia Drugs Distributors
10.3 General Anesthesia Drugs Customer
11 Global General Anesthesia Drugs Market Forecast
11.1 Global General Anesthesia Drugs Consumption Forecast (2021-2025)
11.2 Global General Anesthesia Drugs Forecast by Regions
11.2.1 Global General Anesthesia Drugs Forecast by Regions (2021-2025)
11.2.2 Global General Anesthesia Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global General Anesthesia Drugs Forecast by Type
11.8 Global General Anesthesia Drugs Forecast by Application
12 Key Players Analysis
12.1 Astrazeneca
12.1.1 Company Information
12.1.2 General Anesthesia Drugs Product Offered
12.1.3 Astrazeneca General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Astrazeneca Latest Developments
12.2 Nhwa
12.2.1 Company Information
12.2.2 General Anesthesia Drugs Product Offered
12.2.3 Nhwa General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Nhwa Latest Developments
12.3 Fresenius-Kabi
12.3.1 Company Information
12.3.2 General Anesthesia Drugs Product Offered
12.3.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Fresenius-Kabi Latest Developments
12.4 Baxter Healthcare
12.4.1 Company Information
12.4.2 General Anesthesia Drugs Product Offered
12.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Baxter Healthcare Latest Developments
12.5 B.Braun
12.5.1 Company Information
12.5.2 General Anesthesia Drugs Product Offered
12.5.3 B.Braun General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 B.Braun Latest Developments
12.6 AbbVie
12.6.1 Company Information
12.6.2 General Anesthesia Drugs Product Offered
12.6.3 AbbVie General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 AbbVie Latest Developments
12.7 Hikma Pharmaceuticals
12.7.1 Company Information
12.7.2 General Anesthesia Drugs Product Offered
12.7.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Hikma Pharmaceuticals Latest Developments
12.8 Maruishi
12.8.1 Company Information
12.8.2 General Anesthesia Drugs Product Offered
12.8.3 Maruishi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Maruishi Latest Developments
12.9 Mylan
12.9.1 Company Information
12.9.2 General Anesthesia Drugs Product Offered
12.9.3 Mylan General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Mylan Latest Developments
12.10 Piramal
12.10.1 Company Information
12.10.2 General Anesthesia Drugs Product Offered
12.10.3 Piramal General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Piramal Latest Developments
12.11 Hengrui
12.11.1 Company Information
12.11.2 General Anesthesia Drugs Product Offered
12.11.3 Hengrui General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Hengrui Latest Developments
12.12 Lunan
12.12.1 Company Information
12.12.2 General Anesthesia Drugs Product Offered
12.12.3 Lunan General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Lunan Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. General Anesthesia Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Propofol
Table 5. Major Players of Etomidate
Table 6. Major Players of Midazolam
Table 7. Major Players of Sevoflurane
Table 8. Major Players of Isoflurane
Table 9. Major Players of Others
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global General Anesthesia Drugs Consumption Market Share by Type (2015-2020)
Table 12. Global General Anesthesia Drugs Revenue by Type (2015-2020) ($ million)
Table 13. Global General Anesthesia Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global General Anesthesia Drugs Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global General Anesthesia Drugs Consumption Market Share by Application (2015-2020)
Table 17. Global General Anesthesia Drugs Value by Application (2015-2020)
Table 18. Global General Anesthesia Drugs Value Market Share by Application (2015-2020)
Table 19. Global General Anesthesia Drugs Sale Price by Application (2015-2020)
Table 20. Global General Anesthesia Drugs Sales by Company (2017-2019) (K L)
Table 21. Global General Anesthesia Drugs Sales Market Share by Company (2017-2019)
Table 22. Global General Anesthesia Drugs Revenue by Company (2017-2019) ($ Millions)
Table 23. Global General Anesthesia Drugs Revenue Market Share by Company (2017-2019)
Table 24. Global General Anesthesia Drugs Sale Price by Company (2017-2019)
Table 25. Global General Anesthesia Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players General Anesthesia Drugs Products Offered
Table 27. General Anesthesia Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global General Anesthesia Drugs Consumption by Regions 2015-2020 (K L)
Table 29. Global General Anesthesia Drugs Consumption Market Share by Regions 2015-2020
Table 30. Global General Anesthesia Drugs Value by Regions 2015-2020 ($ Millions)
Table 31. Global General Anesthesia Drugs Value Market Share by Regions 2015-2020
Table 32. Americas General Anesthesia Drugs Consumption by Countries (2015-2020) (K L)
Table 33. Americas General Anesthesia Drugs Consumption Market Share by Countries (2015-2020)
Table 34. Americas General Anesthesia Drugs Value by Countries (2015-2020) ($ Millions)
Table 35. Americas General Anesthesia Drugs Value Market Share by Countries (2015-2020)
Table 36. Americas General Anesthesia Drugs Consumption by Type (2015-2020) (K L)
Table 37. Americas General Anesthesia Drugs Consumption Market Share by Type (2015-2020)
Table 38. Americas General Anesthesia Drugs Consumption by Application (2015-2020) (K L)
Table 39. Americas General Anesthesia Drugs Consumption Market Share by Application (2015-2020)
Table 40. APAC General Anesthesia Drugs Consumption by Countries (2015-2020) (K L)
Table 41. APAC General Anesthesia Drugs Consumption Market Share by Countries (2015-2020)
Table 42. APAC General Anesthesia Drugs Value by Regions (2015-2020) ($ Millions)
Table 43. APAC General Anesthesia Drugs Value Market Share by Regions (2015-2020)
Table 44. APAC General Anesthesia Drugs Consumption by Type (2015-2020) (K L)
Table 45. APAC General Anesthesia Drugs Consumption Market Share by Type (2015-2020)
Table 46. APAC General Anesthesia Drugs Consumption by Application (2015-2020) (K L)
Table 47. APAC General Anesthesia Drugs Consumption Market Share by Application (2015-2020)
Table 48. Europe General Anesthesia Drugs Consumption by Countries (2015-2020) (K L)
Table 49. Europe General Anesthesia Drugs Consumption Market Share by Countries (2015-2020)
Table 50. Europe General Anesthesia Drugs Value by Countries (2015-2020) ($ Millions)
Table 51. Europe General Anesthesia Drugs Value Market Share by Countries (2015-2020)
Table 52. Europe General Anesthesia Drugs Consumption by Type (2015-2020) (K L)
Table 53. Europe General Anesthesia Drugs Consumption Market Share by Type (2015-2020)
Table 54. Europe General Anesthesia Drugs Consumption by Application (2015-2020) (K L)
Table 55. Europe General Anesthesia Drugs Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa General Anesthesia Drugs Consumption by Countries (2015-2020) (K L)
Table 57. Middle East & Africa General Anesthesia Drugs Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa General Anesthesia Drugs Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa General Anesthesia Drugs Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa General Anesthesia Drugs Consumption by Type (2015-2020) (K L)
Table 61. Middle East & Africa General Anesthesia Drugs Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa General Anesthesia Drugs Consumption by Application (2015-2020) (K L)
Table 63. Middle East & Africa General Anesthesia Drugs Consumption Market Share by Application (2015-2020)
Table 64. General Anesthesia Drugs Distributors List
Table 65. General Anesthesia Drugs Customer List
Table 66. Global General Anesthesia Drugs Consumption Forecast by Countries (2021-2025) (K L)
Table 67. Global General Anesthesia Drugs Consumption Market Forecast by Regions
Table 68. Global General Anesthesia Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global General Anesthesia Drugs Value Market Share Forecast by Regions
Table 70. Global General Anesthesia Drugs Consumption Forecast by Type (2021-2025) (K L)
Table 71. Global General Anesthesia Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global General Anesthesia Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global General Anesthesia Drugs Value Market Share Forecast by Type (2021-2025)
Table 74. Global General Anesthesia Drugs Consumption Forecast by Application (2021-2025) (K L)
Table 75. Global General Anesthesia Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global General Anesthesia Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global General Anesthesia Drugs Value Market Share Forecast by Application (2021-2025)
Table 78. Astrazeneca Product Offered
Table 79. Astrazeneca General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)
Table 80. Astrazeneca Main Business
Table 81. Astrazeneca Latest Developments
Table 82. Astrazeneca Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Nhwa Product Offered
Table 84. Nhwa General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)
Table 85. Nhwa Main Business
Table 86. Nhwa Latest Developments
Table 87. Nhwa Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Fresenius-Kabi Product Offered
Table 89. Fresenius-Kabi General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)
Table 90. Fresenius-Kabi Main Business
Table 91. Fresenius-Kabi Latest Developments
Table 92. Fresenius-Kabi Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Baxter Healthcare Product Offered
Table 94. Baxter Healthcare General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)
Table 95. Baxter Healthcare Main Business
Table 96. Baxter Healthcare Latest Developments
Table 97. Baxter Healthcare Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. B.Braun Product Offered
Table 99. B.Braun General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)
Table 100. B.Braun Main Business
Table 101. B.Braun Latest Developments
Table 102. B.Braun Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. AbbVie Product Offered
Table 104. AbbVie General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)
Table 105. AbbVie Main Business
Table 106. AbbVie Latest Developments
Table 107. AbbVie Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Hikma Pharmaceuticals Product Offered
Table 109. Hikma Pharmaceuticals Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Hikma Pharmaceuticals Main Business
Table 111. Hikma Pharmaceuticals Latest Developments
Table 112. Hikma Pharmaceuticals General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)
Table 113. Maruishi Product Offered
Table 114. Maruishi General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)
Table 115. Maruishi Main Business
Table 116. Maruishi Latest Developments
Table 117. Maruishi Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Mylan Product Offered
Table 119. Mylan General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)
Table 120. Mylan Main Business
Table 121. Mylan Latest Developments
Table 122. Mylan Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Piramal Product Offered
Table 124. Piramal General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)
Table 125. Piramal Main Business
Table 126. Piramal Latest Developments
Table 127. Piramal Basic Information, Company Total Revenue (in $ million), General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Hengrui Product Offered
Table 129. Hengrui General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)
Table 130. Hengrui Main Business
Table 131. Hengrui Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 132. Hengrui Latest Developments
Table 133. Lunan Product Offered
Table 134. Lunan General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2020E)
Table 135. Lunan Main Business
Table 136. Lunan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 137. Lunan Latest Developments
List of Figures
Figure 1. Picture of General Anesthesia Drugs
Figure 2. General Anesthesia Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global General Anesthesia Drugs Consumption Growth Rate 2015-2025 (K L)
Figure 5. Global General Anesthesia Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Propofol
Figure 7. Product Picture of Etomidate
Figure 8. Product Picture of Midazolam
Figure 9. Product Picture of Sevoflurane
Figure 10. Product Picture of Isoflurane
Figure 11. Product Picture of Others
Figure 12. Global General Anesthesia Drugs Consumption Market Share by Type (2015-2020)
Figure 13. Global General Anesthesia Drugs Value Market Share by Type (2015-2020)
Figure 14. General Anesthesia Drugs Consumed in Intravenous Anesthetics
Figure 15. Global General Anesthesia Drugs Market: Intravenous Anesthetics (2015-2020) (K L)
Figure 16. Global General Anesthesia Drugs Market: Intravenous Anesthetics (2015-2020) ($ Millions)
Figure 17. General Anesthesia Drugs Consumed in Inhalational Anesthetics
Figure 18. Global General Anesthesia Drugs Market: Inhalational Anesthetics (2015-2020) (K L)
Figure 19. Global General Anesthesia Drugs Market: Inhalational Anesthetics (2015-2020) ($ Millions)
Figure 20. Global General Anesthesia Drugs Consumption Market Share by Application (2015-2020)
Figure 21. Global General Anesthesia Drugs Value Market Share by Application (2015-2020)
Figure 22. Global General Anesthesia Drugs Sales Market Share by Company in 2017
Figure 23. Global General Anesthesia Drugs Sales Market Share by Company in 2019
Figure 24. Global General Anesthesia Drugs Revenue Market Share by Company in 2017
Figure 25. Global General Anesthesia Drugs Revenue Market Share by Company in 2019
Figure 26. Global General Anesthesia Drugs Sale Price by Company in 2019
Figure 27. Global General Anesthesia Drugs Consumption Market Share by Regions 2015-2020
Figure 28. Global General Anesthesia Drugs Value Market Share by Regions 2015-2020
Figure 29. Americas General Anesthesia Drugs Consumption 2015-2020 (K L)
Figure 30. Americas General Anesthesia Drugs Value 2015-2020 ($ Millions)
Figure 31. APAC General Anesthesia Drugs Consumption 2015-2020 (K L)
Figure 32. APAC General Anesthesia Drugs Value 2015-2020 ($ Millions)
Figure 33. Europe General Anesthesia Drugs Consumption 2015-2020 (K L)
Figure 34. Europe General Anesthesia Drugs Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa General Anesthesia Drugs Consumption 2015-2020 (K L)
Figure 36. Middle East & Africa General Anesthesia Drugs Value 2015-2020 ($ Millions)
Figure 37. Americas General Anesthesia Drugs Consumption Market Share by Countries in 2019
Figure 38. Americas General Anesthesia Drugs Value Market Share by Countries in 2019
Figure 39. Americas General Anesthesia Drugs Consumption Market Share by Type in 2019
Figure 40. Americas General Anesthesia Drugs Consumption Market Share by Application in 2019
Figure 41. United States General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 42. United States General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 43. Canada General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 44. Canada General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 46. Mexico General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 47. APAC General Anesthesia Drugs Consumption Market Share by Countries in 2019
Figure 48. APAC General Anesthesia Drugs Value Market Share by Regions in 2019
Figure 49. APAC General Anesthesia Drugs Consumption Market Share by Type in 2019
Figure 50. APAC General Anesthesia Drugs Consumption Market Share by Application in 2019
Figure 51. China General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 52. China General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 53. Japan General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 54. Japan General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 55. Korea General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 56. Korea General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 58. Southeast Asia General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 59. India General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 60. India General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 61. Australia General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 62. Australia General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 63. Europe General Anesthesia Drugs Consumption Market Share by Countries in 2019
Figure 64. Europe General Anesthesia Drugs Value Market Share by Countries in 2019
Figure 65. Europe General Anesthesia Drugs Consumption Market Share by Type in 2019
Figure 66. Europe General Anesthesia Drugs Consumption Market Share by Application in 2019
Figure 67. Germany General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 68. Germany General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 69. France General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 70. France General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 71. UK General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 72. UK General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 73. Italy General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 74. Italy General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 75. Russia General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 76. Russia General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa General Anesthesia Drugs Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa General Anesthesia Drugs Value Market Share by Countries in 2019
Figure 79. Middle East & Africa General Anesthesia Drugs Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa General Anesthesia Drugs Consumption Market Share by Application in 2019
Figure 81. Egypt General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 82. Egypt General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 84. South Africa General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 85. Israel General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 86. Israel General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 88. Turkey General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries General Anesthesia Drugs Consumption Growth 2015-2020 (K L)
Figure 90. GCC Countries General Anesthesia Drugs Value Growth 2015-2020 ($ Millions)
Figure 91. Global General Anesthesia Drugs Consumption Growth Rate Forecast (2021-2025) (K L)
Figure 92. Global General Anesthesia Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 94. Americas General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 95. APAC General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 96. APAC General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 97. Europe General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 98. Europe General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 100. Middle East & Africa General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 101. United States General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 102. United States General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 103. Canada General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 104. Canada General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 105. Mexico General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 106. Mexico General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 107. Brazil General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 108. Brazil General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 109. China General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 110. China General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 111. Japan General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 112. Japan General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 113. Korea General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 114. Korea General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 116. Southeast Asia General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 117. India General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 118. India General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 119. Australia General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 120. Australia General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 121. Germany General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 122. Germany General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 123. France General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 124. France General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 125. UK General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 126. UK General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 127. Italy General Anesthesia Drugs Consumption 2021-2025 (K L)
Figure 128. Italy General Anesthesia Drugs Value 2021-2025 ($ Millions)
Figure 129. Ru
Global Sevoflurane Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 90
According to our LPI (LP Information) latest study, the global Sevoflurane market size was valued at US$ 1293.8 million in 2023. With growing demand in downstream market, the Sevoflurane is forecast to a readjusted size of US$ 1247.6 million by 2030 with a CAGR of -0.5% during review period.
The research report highlights the growth potential of the global Sevoflurane market. Sevoflurane are expected to show stable growth in the future market. However, product differentiation, reducing c......
Global Remifentanil Hydrochloride Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Remifentanil Hydrochloride market size was valued at US$ million in 2023. With growing demand in downstream market, the Remifentanil Hydrochloride is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Remifentanil Hydrochloride market. Remifentanil Hydrochloride are expected to show stable growth in the future market. How......
Global General Anesthesia Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 111
According to our LPI (LP Information) latest study, the global General Anesthesia Drugs market size was valued at US$ 3840.3 million in 2023. With growing demand in downstream market, the General Anesthesia Drugs is forecast to a readjusted size of US$ 4929.3 million by 2030 with a CAGR of 3.6% during review period.
The research report highlights the growth potential of the global General Anesthesia Drugs market. General Anesthesia Drugs are expected to show stable growth in the future m......
Global Sevoflurane Source Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 90
According to our LPI (LP Information) latest study, the global Sevoflurane Source market size was valued at US$ 1192.7 million in 2023. With growing demand in downstream market, the Sevoflurane Source is forecast to a readjusted size of US$ 1509.6 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Sevoflurane Source market. Sevoflurane Source are expected to show stable growth in the future market. However, product ......
Global Anesthesia Drugs Market Research Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 2680 Onwards Pages: 166
Anesthesia is the practice of administering medicines that block the feeling of pain or other sensations to allow medical or surgical operations to take place without causing undue distress or discomfort.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while takin......
Global Anesthesia Drugs Professional Survey Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 3280 Onwards Pages: 108
Anesthesia is the practice of administering medicines that block the feeling of pain or other sensations to allow medical or surgical operations to take place without causing undue distress or discomfort.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while takin......
Global Sevoflurane Professional Survey Report 2023, Forecast to 2028
Published: 22-Nov-2023 Price: US 3280 Onwards Pages: 109
Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. T......
Global Sevoflurane Market Research Report 2023, Forecast to 2028
Published: 22-Nov-2023 Price: US 2680 Onwards Pages: 132
Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. T......
Global Sevoflurane Source Market Research Report 2023, Forecast to 2028
Published: 14-Nov-2023 Price: US 2680 Onwards Pages: 137
Sevoflurane Source is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerg......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
